Insulin resistance and dyslipidaemia in obese premenopausal and postmenopausal women matched for leg/trunk fat mass ratio

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 69, Issue 4, 2009, Pages 505-511

  Aasen, Gunnar ^a   Fagertun, Hans ^b   Halse, Johan ^a  

^a Spesialistsenteret Pilestredet Park   (Norway)

^b Capturo AS   (Norway)

Author keywords

Age; body composition; hormones; menopause

Indexed keywords

C PEPTIDE; CHOLESTEROL; ESTRADIOL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; LIOTHYRONINE; LIPID; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TESTOSTERONE; THYROXINE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; ESTRADIOL BLOOD LEVEL; FEMALE; GLUCOSE METABOLISM; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEG; LIOTHYRONINE BLOOD LEVEL; LIPID BLOOD LEVEL; LIPID METABOLISM; METABOLIC REGULATION; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; THYROXINE BLOOD LEVEL; TRUNK;

ABDOMEN; ADIPOSITY; ADULT; DYSLIPIDEMIAS; FEMALE; HUMANS; INSULIN RESISTANCE; LEG; MIDDLE AGED; OBESITY; POSTMENOPAUSE; PREMENOPAUSE;

EID: 67651149750     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510902778734     Document Type: Article

References (44)

1. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willet WC, Manson JE. Abdominal adiposity and coronary heart disease in women. J Am Med Assoc. 1998;280:1843-8.
2. Kanaya AM, Vittinghoff E, Shlipak MG, Resnick HE, Visser M, Grady D, Barret-Connor E. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol. 2003;158:1161-70.
3. Carey VJ, Walters EE, Colditz GA, Solomon CG, Willett WC, Rosner BA, Speizer FE, Manson JE. Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol. 1997;145:614-19.
4. Toth MJ, Tchernof A, Sites CK, Poehlman ET. Menopause-related changes in body fat distribution. Ann NY Acad Sci. 2000;904:502-6.
5. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Int Med. 1995;123:673-5.
6. Svendsen OL, Hassager C, Christiansen C. Age- and menopause-associated variations in body composition and fat distribution in healthy women as measured by dual-energy X-ray absorptiometry. Metabolism. 1995;44:369-73.
7. Tremolieres FA, Pouilles JM, Ribot CA. Relative influence of age and menopause on total and regional body composition changes in postmenopausal women. Am J Obstet Gynecol. 1996;175:1594-600.
8. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992;55:950-4.
9. Panotopoulos G, Ruiz JC, Raison C, Guy-Grand B, Basdevant A. Menopause, fat and lean distribution in obese women. Maturitas. 1996;25:11-19.
10. Gambacciani M, Ciaponi M, Cappagli B, Piaggesi L, De Simone L, Orlandi R, Genazzani AR. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab. 1997;82:414-17.
11. Toth MJ, Sites CK, Eltabbakh GH, Poehlman ET. Effect of menopausal status on insulin-stimulated glucose disposal. Comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care. 2000;23:801-6.
12. DeNino WF, Tchernof A, Dionne I, Toth MJ, Ades PA, Sites CK, Poehlman ET. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy non-obese women. Diabetes Care. 2001;24:925-32.
13. Van Pelt RE, Evans EM, Schechtman KB, Ehsani AA, Kohrt WM. Contribution of total and regional fat mass to risk for cardiovascular disease in older women. Am J Physiol Endocrinol Metab. 2002;282:E1023-8.
14. Van Pelt RE, Jankowski CM, Gozansky WS, Schwartz RS, Kohrt WM. Lower-body adiposity and metabolic protection in postmenopausal women. J Clin Endocrinol Metab. 2005;90:4573-8.
15. Tatsukawa M, Kurokawa M, Tamari Y, Yoshimatsu H, Sakata T. Regional fat deposition in the legs is useful as a presumptive marker of antiatherogenisity. Japanese Proc Soc Exp Bio Med. 2000;223:156-62.
16. Tankó LB, Bagger YZ, Alexandersen P, Larsen PJ, Christiansen C. Peripheral adiposity exhibits an independent dominant antiatherogenic effect in elderly women. Circulation. 2003;107:1626-31.
17. Snijder MB, Dekker JM, Visser M, Bouter LM, Stehouwer CD, Yudkin JS, Heine RJ, Nijpels G, Seidell JC. Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels. Diabetes Care. 2004;27:372-7.
18. Aasen G, Fagertun H, Halse J. Body composition analysis by dual X-ray absorptiometry: in vivo and in vitro comparison of three different fan-beam instruments. Scand J Clin Lab Invest. 2006;66:659-66.
19. Aasen G, Fagertun H, Halse J. Regional fat mass by DXA: high leg fat mass attenuates the relative risk of insulin resistance and dyslipidemia in obese but not in overweight postmenopausal women. Scand J Clin Lab Invest. 2008;68:204-11.
20. Aasen G, Fagertun H, Halse J. Leg fat mass measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men. Scand J Clin Lab Invest. Epub ahead of publication (2008).
21. Matthews DR, Hosker JP, Rudenski AS, Maylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-19.
22. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggianai F, Zenner MB, Monauni T, Muggero M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care. 2000;23:57-63.
23. Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85:2402-10.
24. Yokoyama H, Emoto M, Fujiwara S, Motomyama K, Morioka T, Komatsu M, Tahara H, Shoji T, Nishizawa Y. Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal weight range and moderately obese type 2 diabetic patients. Diabetes Care. 2003;26:426-32.
25. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Jarvinen HY, Van Haften T, Renn W, Gerich J. Use of the oral tolerance test to assess insulin release and insulin sensitivity. Diabetes Care. 2000;23:295-301.
26. Friedewald WR, Levy RI, Fredichson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
27. Pascot A, Lemieux S, Lemieux I, Prud'homme D, Tremblay A, Bouchard C, Nadeau A, Couillard C, Tchernof A, Bergeron J, Despres J-P. Age-related increase in visceral adipose tissue and body fat and the metabolic risk profile of premenopausal women. Diabetes Care. 1999;22:1471-8.
28. Ferranini E, Vichi S, Beck-Nielsen H, Laakso M, Paolisso G, Smith U, European Group for the Study of Insulin Resistance (EGIR): Insulin action and age. Diabetes. 1999;45:947-53.
29. Tchernof A, Poehlman ET, Despres J-P. Body fat distribution, the menopause transition, and hormone replacement therapy. Diabetes Metab (Paris). 2000;26:12-20.
30. Brochu M, Mathieu ME, Karelis ED, Doucet E, Lavoie ME, Garrel D, Rabasa-Lhoret R. Contribution to the lean body mass to insulin resistance in postmenopausal women with visceral obesity: a Monet study. Obesity (Silver Spring). 2008;16:1085-93.
31. Goulet ED, Lord C, Chaput JP, Aubertin-Leheudre M, Brochu M, Dionne IJ. No difference in insulin sensitivity between healthy postmenopausal women with or without sarcopenia: a pilot study. Appl Physiol Nutr Metab. 2007;32:426-33.
32. Aubertin-Leheudre M, Lord C, Goulet ED, Dionne IJ. Effect of sarcopenia on cardiovascular disease risk factors in obese postmenopausal women. Obesity (Silver Spring). 2006;14:2277-83.
33. Svendsen OL, Hassager C, Christiansen C. Relationships and independence of body composition, sex hormones, fat distribution and other cardiovascular risk factors in overweight postmenopausal women. Int J Obes. 1993;17:459-63.
34. Tchernof A, Toth MJ, Poehlman ET. Sex hormone-binding globulin levels in middle-aged premenopausal women. Diabetes Care. 1999;22:1875-81.
35. Nestler JE. Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance (Editorial). J Clin Endocrinol Metab. 1993;76:273-4.
36. Preziosi P, Barrett-Connor E, Papoz L, Roger M, Saint-Paul M, Nahoul K, Simon D. Interrelation between plasma sex hormone binding globulin and plasma insulin in healthy adult women: the Telecom study. J Clin Endocrinol Metab. 1993;76:283-7.
37. Weinberg ME, Manson JE, Buring JE, Cook N, Seely EW, Ridker PM, Rexrode KM. Low sex-hormone binding globulin is associated with the metabolic syndrome in postmenopausal women. Metabolism. 2006;55:1473-80.
38. Munoz J, Derstine A, Gower BA. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obes Res. 2002;10:424-31.
39. Paradisi G, Smith L, Burtner C, Leaming R, Garvey WT, Hook G, Johnson A, Cronin J, Steinberg HO, Baron AD. Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome. Diabetes Care. 1999;22:1310-17.
40. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Merman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab. 2002;87:4166-70
41. Ricart W, Fernandez-Real J-M. No decrease in free IGF-1 with increasing insulin in obesity-related insulin resistance. Obes Res. 2001;9:631-6.
42. Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J. The IGF-1 system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Horm IGF Res. 2004;14:91-6.
43. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC, Huh KB. Effect of obesity on total and free insulin-like growth factor (IGF-1), and their relationship to IGF-binding protein (BP)-1, IGFB-2, IGFB-3, insulin and growth hormone. Int J Obes. 1997;21:355-9.
44. Hanley AJG, Williams K, Stern MP, Haffner SM. Homeostasis model assessment of insulin resistance of cardiovascular disease. The San Antonio Heart Study. Diabetes Care. 2002;25:1177-84.